The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / D•• B•••••••••

••• Locked

Add-on acquisitionannouncedadd-onannounced Jul 6, 2026Fact
What happened
Target
D•• B•••••••••
Platform
S•••••• S•••••••• L••add-on basis: S•••••• S•••••••• L•• ("S•••••• S••••••••"), a portfolio company of NMS Capital ("NMS"), announced today the acquisition of D•• B••••••••• ("DCM Bio" or the "Company"), a Frederick, Maryland-based provider of laboratory automation maintenance, repair, technical support, and integration solutions.
Control
Control
Share acquired
unknown
Industry
industrials / automation
Target location
MD, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
7 named
Buy side
Financing side
  • T•• T••• B•••• C•••••• P•••••••Lenderconfirmed
    “••• Locked”
Advisory side
  • D••• M••••• L••Legal adviserconfirmed
    “••• Locked”
Side not stated
Evidence
“••• Locked”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026